Yahoo Web Search

Search results

  1. Amprion Amplifies Neurological Diagnosis. SYNTap Test helps doctors diagnose LBD and Parkinson's accurately. Our breakthrough test detects misfolded Synuclein, a biomarker related to these diseases.

    • SYNTap® Test

      SYNTap® Test - Amprion's SYNTap Test - Diagnostic Test For...

    • Collaborations

      To improve patient access to the SYNTap® Biomarker CSF Test,...

    • Amprion News

      Amprion News - Amprion's SYNTap Test - Diagnostic Test For...

    • FAQ

      FAQ - Amprion's SYNTap Test - Diagnostic Test For LBD &...

    • References

      References - Amprion's SYNTap Test - Diagnostic Test For LBD...

    • Downloads

      Downloads - Amprion's SYNTap Test - Diagnostic Test For LBD...

  2. Jan 1, 2024 · Amprion’s mission: To revolutionize brain disease diagnosis. Through molecular testing, we aim to accelerate precision medicine for neurodegenerative disorders. Scientific Journey. As a pioneer in detecting misfolded proteins, we believe precision medicine is the new frontier.

    • Amprion1
    • Amprion2
    • Amprion3
    • Amprion4
    • Amprion5
  3. Oct 5, 2021 · San Francisco, CA | Oct. 6th, 2021 — Amprion has announced the commercial rollout of its innovative SYNTap Biomarker Test, a first-in-class laboratory-developed test (LDT) for accurate and reliable detection of α-synuclein aggregates, a hallmark in various brain diseases.

  4. www.amprion.net › index-2Amprion connects

    Amprion GmbH is one of four transmission system operators in Germany. Our 11,000 kilometre-long extra-high voltage grid transports electricity in an area from the North Sea to the Alps. One third of Germany's economic output is generated there. Our lines are the lifelines of society: they secure jobs and quality of life for 29 million people.

  5. en.wikipedia.org › wiki › AmprionAmprion - Wikipedia

    Website. http://www.amprion.net. Amprion GmbH (formerly RWE Transportnetz Strom GmbH) is one of the four transmission system operators for electricity in Germany with approx. 2300 employees. It is a member of European Network of Transmission System Operators for Electricity (ENTSO-E).

  6. Dec 14, 2021 · December 14, 2021. Currently, Parkinson’s disease (PD) diagnosis is based on a visual clinical exam, done by a doctor (ideally a neurologist or movement disorder specialist) in their office.

  7. May 28, 2019 · The U.S Food and Drug Administration (FDA) has granted a Breakthrough Device designation to Amprion’s proprietary technology, Protein Misfolding Cyclic Amplification (PMCA) — a device that holds the potential to diagnose Parkinson’s disease at a much earlier stage than current diagnostic methods.

  8. People also ask

  1. People also search for